A Randomized Study Evaluating Patients Discharged with Indwelling Chest Tube and Valve
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 17-007774
NCT ID: NCT03943511
Sponsor Protocol Number: 17-007774
About this study
The purpose of this study is to analyze the effectiveness of antibiotics and closer monitoring on decreasing infection in patients discharging with a chest tube and valve in place.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- ≥ 18 years of age.
- Male or Female.
- Consultation with a thoracic surgeon.
- Discharge from the hospital with a chest tube and valve in place.
- Subject is able to understand the study procedures and provide informed consent.
Exclusion Criteria:
- Pregnancy.
- Allergy to cephalexin or clindamycin.
- Special consideration should be taken in enrolling subjects with preexisting conditions that can be exacerbated by antibiotic use but are allowed at the discretion of the treating physician.
- Considerations include but are not limited to:
- C. difficile;
- Colitis;
- Impaired renal function;
- Hypersensitivities to cephalosporins, penicillins, or lincomycin;
- Hepatic impairment;
- Anticoagulation therapy;
- Metformin usage;
- Probenecid usage.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator K Robert Shen, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available